Company intelligence / Profile preview

Breyer Capital

Austin, Texas, United States

Ownership: Private
Development stage: Other

Overview

Breyer Capital is a prominent venture capital and private equity firm investing in breakthrough biomedical technologies and innovative healthcare models, with a long-term, early-stage, and hands-on approach. The firm is recognized for backing AI-driven diagnostics, programmable medicines, advanced data infrastructure, and transformative health delivery systems[2][5][7][8].

Industry: Investors

Partnerships

Harvard Medical School Department of Biomedical Informatics (AIM PhD track and AI-driven medicine)[5]Co-investors (e.g., A16z Crypto, Goldman Sachs, NEA, Fifth Wall) on select deals[4]

Beyond the preview

Go deeper on Breyer Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Breyer Capital.

Explore the full profile